260 related articles for article (PubMed ID: 11827669)
1. [Abnormalities in coagulation and fibrinolysis in septic shock with purpura].
Sánchez Miralles A; Reig Sáenz R; Marco Vera P; Muñoz Pérez F; Alvarez Sánchez B; Sebastián Muñoz I
An Esp Pediatr; 2002 Feb; 56(2):99-103. PubMed ID: 11827669
[TBL] [Abstract][Full Text] [Related]
2. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
[TBL] [Abstract][Full Text] [Related]
3. Systemic coagulation and fibrinolysis in patients with or at risk for the adult respiratory distress syndrome.
Groeneveld AB; Kindt I; Raijmakers PG; Hack CE; Thijs LG
Thromb Haemost; 1997 Dec; 78(6):1444-9. PubMed ID: 9423792
[TBL] [Abstract][Full Text] [Related]
4. Mortality rates in pediatric septic shock with and without multiple organ system failure.
Kutko MC; Calarco MP; Flaherty MB; Helmrich RF; Ushay HM; Pon S; Greenwald BM
Pediatr Crit Care Med; 2003 Jul; 4(3):333-7. PubMed ID: 12831416
[TBL] [Abstract][Full Text] [Related]
5. Relation between coagulation/fibrinolysis and lactate in the course of human septic shock.
Hartemink KJ; Hack CE; Groeneveld AB
J Clin Pathol; 2010 Nov; 63(11):1021-6. PubMed ID: 20870661
[TBL] [Abstract][Full Text] [Related]
6. Age-related differences in outcome and severity of DIC in children with septic shock and purpura.
Hazelzet JA; Risseeuw-Appel IM; Kornelisse RF; Hop WC; Dekker I; Joosten KF; de Groot R; Hack CE
Thromb Haemost; 1996 Dec; 76(6):932-8. PubMed ID: 8972013
[TBL] [Abstract][Full Text] [Related]
7. Tight glycemic control may favor fibrinolysis in patients with sepsis.
Savioli M; Cugno M; Polli F; Taccone P; Bellani G; Spanu P; Pesenti A; Iapichino G; Gattinoni L
Crit Care Med; 2009 Feb; 37(2):424-31. PubMed ID: 19114908
[TBL] [Abstract][Full Text] [Related]
8. Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock.
Vervloet MG; Thijs LG; Hack CE
Semin Thromb Hemost; 1998; 24(1):33-44. PubMed ID: 9515778
[TBL] [Abstract][Full Text] [Related]
9. The tissue factor and plasminogen activator inhibitor type-1 response in pediatric sepsis-induced multiple organ failure.
Green J; Doughty L; Kaplan SS; Sasser H; Carcillo JA
Thromb Haemost; 2002 Feb; 87(2):218-23. PubMed ID: 11858480
[TBL] [Abstract][Full Text] [Related]
10. Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality.
Fijnvandraat K; Derkx B; Peters M; Bijlmer R; Sturk A; Prins MH; van Deventer SJ; ten Cate JW
Thromb Haemost; 1995 Jan; 73(1):15-20. PubMed ID: 7740486
[TBL] [Abstract][Full Text] [Related]
11. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
12. Surviving meningococcal septic shock: health consequences and quality of life in children and their parents up to 2 years after pediatric intensive care unit discharge.
Buysse CM; Raat H; Hazelzet JA; Hop WC; Maliepaard M; Joosten KF
Crit Care Med; 2008 Feb; 36(2):596-602. PubMed ID: 18216608
[TBL] [Abstract][Full Text] [Related]
13. TAFI and PAI-1 levels in human sepsis.
Zeerleder S; Schroeder V; Hack CE; Kohler HP; Wuillemin WA
Thromb Res; 2006; 118(2):205-12. PubMed ID: 16009400
[TBL] [Abstract][Full Text] [Related]
14. Time course of hemostatic abnormalities in sepsis and its relation to outcome.
Lorente JA; García-Frade LJ; Landín L; de Pablo R; Torrado C; Renes E; García-Avello A
Chest; 1993 May; 103(5):1536-42. PubMed ID: 8486040
[TBL] [Abstract][Full Text] [Related]
15. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.
de Kleijn ED; de Groot R; Hack CE; Mulder PG; Engl W; Moritz B; Joosten KF; Hazelzet JA
Crit Care Med; 2003 Jun; 31(6):1839-47. PubMed ID: 12794428
[TBL] [Abstract][Full Text] [Related]
16. [The multiple-organ failure syndrome in acute pancreatitis. Its pathogenesis and treatment].
Visconti M; Rabitti PG; Uomo G; Giannattasio F; Varriale M; Russo C
Recenti Prog Med; 1995 Feb; 86(2):81-5. PubMed ID: 7754179
[TBL] [Abstract][Full Text] [Related]
17. [Fibrinolysis system in patients with sepsis in state of myelotoxic agranulocytosis].
Galstian GM; Krechetova AV; Vasil'ev SA; Orel EB; Pustovoĭt LA; Egorova EO; Saridi EIu; Gemdzhian EG; Gorodetskiĭ VM
Anesteziol Reanimatol; 2012; (2):41-8. PubMed ID: 22834287
[TBL] [Abstract][Full Text] [Related]
18. Extracellular hsp70 levels in children with septic shock.
Wheeler DS; Fisher LE; Catravas JD; Jacobs BR; Carcillo JA; Wong HR
Pediatr Crit Care Med; 2005 May; 6(3):308-11. PubMed ID: 15857530
[TBL] [Abstract][Full Text] [Related]
19. Factor XIII in severe sepsis and septic shock.
Zeerleder S; Schroeder V; Lämmle B; Wuillemin WA; Hack CE; Kohler HP
Thromb Res; 2007; 119(3):311-8. PubMed ID: 16574200
[TBL] [Abstract][Full Text] [Related]
20. Elevation of brain natriuretic peptide levels in children with septic shock.
Domico M; Liao P; Anas N; Mink RB
Pediatr Crit Care Med; 2008 Sep; 9(5):478-83. PubMed ID: 18679143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
